Biologics for the Treatment of Severe Acrodermatitis Continua of Hallopeau: Report of Two Cases Successfully Treated with Ixekizumab and Ustekinumab

Biologics for the Treatment of Severe Acrodermatitis Continua of Hallopeau: Report of Two Cases Successfully Treated with Ixekizumab and Ustekinumab

Bibliographic Details
Main Authors:	Luigi Gargiulo, Francesco Toso, Luciano Ibba, Mario Valenti, Antonio Costanzo, Alessandra Narcici
Format:	Article
Language:	English
Published:	Mattioli1885 2023-04-01
Series:	Dermatology Practical & Conceptual
Subjects:	psoriasis acrodermatitis continua of Hallopeau ixekizumab ustekinumab biologics
Online Access:	https://dpcj.org/index.php/dpc/article/view/2740

Similar Items

Treatment of acrodermatitis continua of hallopeau with ixekizumab
by: Austinn C. Miller, et al.
Published: (2021-01-01)

Acrodermatitis continua Hallopeau
by: Julia Nowowiejska, et al.
Published: (2021-05-01)

Acrodermatitis continua of Hallopeau: clinical perspectives
by: Smith MP, et al.
Published: (2019-08-01)

Acrodermatitis Continua of Hallopeau with Bone Resorption in an 8-Year-Old Patient: A Case Report
by: May Alorainy, et al.
Published: (2017-12-01)

ACRODERMATITIS CONTINUA SUPPURATIVA HALLOPEAU IN COMBINATION WITH LOCALIZED PSORIASIS VULGARIS
by: E. V. Sokolovskiy, et al.
Published: (2017-10-01)

Successful treatment of acrodermatitis continua of Hallopeau coexisting with generalized pustular psoriasis with spesolimab: a case report
by: Pengfei Wen, et al.
Published: (2024-02-01)

Acrodermatitis continua of Hallopeau with psoriatic arthritis treated with biologics and apremilast
by: Shohei Igari, et al.
Published: (2023-09-01)

Lingual Pustular Psoriasis and Acrodermatitis Continua of Hallopeau Successfully Treated with Adalimumab: A Rare Case Report and Review of Oral Psoriasis
by: Sarah J.J. Touyz, et al.
Published: (2018-10-01)

Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S)
by: Norman Wasel, et al.
Published: (2020-05-01)

Acrodermatitis continua of Hallopeau and psoriatic arthritis: A case report
by: Carolina García, et al.
Published: (2020-09-01)

Acrodermatitis continua of Hallopeau successfully treated with secukinumab
by: Riccardo Balestri, et al.
Published: (2018-11-01)

Long-term management of pediatric psoriasis with ixekizumab: a case report
by: Diego Orsini, et al.
Published: (2023-12-01)

Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study
by: Paolo Gisondi, et al.
Published: (2022-07-01)

Greater cumulative benefits from ixekizumab versus ustekinumab treatment over 52 weeks for patients with moderate-to-severe psoriasis in a randomized, double-blinded phase 3b clinical trial
by: Andrew Blauvelt, et al.
Published: (2020-02-01)

Acute Generalized Pustular Psoriasis Developed Resistance to Adalimumab Was Successfully Treated with Narrowband Ultraviolet B and Acitretin: A Case Report
by: Yang X, et al.
Published: (2022-11-01)

Pustular Psoriasis: From Pathophysiology to Treatment
by: Giovanni Genovese, et al.
Published: (2021-11-01)

Ixekizumab for the treatment of acrodermatitis continua of hallopeau and inverse psoriasis
by: Rui Yuan Xia, et al.
Published: (2023-01-01)

Acrodermatitis Continua of Hallopeau Successfully Treated with Ustekinumab: A Case Report and Literature Review
by: Shi L, et al.
Published: (2023-04-01)

Pemphigus vegetans of hallopeau
by: Nanda Soni, et al.
Published: (2005-01-01)

Ixekizumab
by: İlgen Ertam Sağduyu
Published: (2022-04-01)

Ixekizumab May Improve Renal Function in Psoriasis
by: Giuseppe Fabrizio Amoruso, et al.
Published: (2021-05-01)

Disease response and patient-reported outcomes among initiators of ixekizumab
by: Mona Shahriari, et al.
Published: (2022-04-01)

Erythrodermic psoriasis after discontinuation of ixekizumab
by: Kathryn Anne Potter, MD, et al.
Published: (2018-01-01)

Toxoplasmosis in a patient receiving ixekizumab for psoriasis
by: Yolanka Lobo, BPhysio, MBBS, et al.
Published: (2020-03-01)

An Atypical Case of Pustular Psoriasis Presenting With Severe Subungual Abscesses Involving All Fingers
by: A. Tulin Mansur
Published: (2019-04-01)

Dermoscopy of acrodermatitis continua of Hallopeau
by: Setu Mittal, et al.
Published: (2023-01-01)

Effectiveness and safety of ustekinumab for the treatment of psoriasis; six years of clinical experience
by: Melis Gönülal, et al.
Published: (2023-12-01)

Ixekizumab treatment patterns and healthcare utilization and costs for patients with psoriasis
by: Mwangi J. Murage, et al.
Published: (2021-01-01)

No need to change the drug class: ixekizumab- following secukinumab-therapy in psoriasis
by: Therezia Bokor-Billmann, et al.
Published: (2019-04-01)

Severe Generalized Pustular Psoriasis Successfully Treated with Ixekizumab: A Case Report
by: Martina Burlando, et al.
Published: (2022-11-01)

Efficacy and safety of ustekinumab in adolescents
by: Kellen R, et al.
Published: (2016-09-01)

Treatment and molecular profiling of acrodermatitis continua of Hallopeau during pregnancy using targeted therapy
by: Sara Al-Khawaga, MD, et al.
Published: (2021-10-01)

Role of IL-17 in plaque psoriasis: therapeutic potential of ixekizumab
by: Hanley TL, et al.
Published: (2017-03-01)

Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience
by: Martora F, et al.
Published: (2023-01-01)

Acrodermatitis dysmetabolica secondary to isoleucine deficiency in infant with maple syrup urine disease
by: Fares A. Alkhayal, et al.
Published: (2023-08-01)

comment: A study on efficacy of oral zinc therapy for treatment of acrodermatitis enteropathica
by: Miloš Jeseňák
Published: (2013-04-01)

Late reaction to ustekinumab infusion
by: Marina Resener Morais, et al.
Published: (2013-09-01)

Ustekinumab en psoriasis cutánea y artritis psoriásica
by: Javier E. Rosa, et al.
Published: (2015-06-01)

A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
by: Bruce W. Kirkham, et al.
Published: (2023-07-01)

Absolute and Relative Psoriasis Area and Severity Indices (PASI) for Comparison of the Efficacy of Ixekizumab to Etanercept and Placebo in Patients with Moderate-to-severe Plaque Psoriasis: An Integrated Analysis of UNCOVER-2 and UNCOVER-3 Outcomes
by: Luís Puig, et al.
Published: (2019-08-01)